Advertisement
Advertisement

PLSE

PLSE logo

Pulse Biosciences, Inc Common Stock (DE)

17.37
USD
+0.44
+2.62%
Mar 07, 15:59 UTC -5
Closed
exchange

After-Market

17.37

0
0.00%

Pulse Biosciences, Inc Common Stock (DE) Profile

About

Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications which include human oncology, dermatology, aesthetics and other minimally invasive applications. Pulse Biosciences, Inc. is based in Burlingame, California.

Info & Links

CEO

Kevin P. Danahy

Headquarters

3957 POINT EDEN WAY
HAYWARD, CA 94545, UNITED STATES

Industry

Medical Instruments

Sector

Medical

Website

www.pulsebiosciences.com

Auditor

Deloitte & Touche LLP

Share holders

11

Employees

56

Pulse Biosciences, Inc Common Stock (DE) Statistics

Valuation Measures

Market Capitalization2

1.06B

Enterprise Value

984.50M

Enterprise Value/EBITDA(ttm)

-20.80

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

15.55

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-96.89%

Return on Invested Capital(ttm)

-113.07%

Return on Assets(ttm)

-74.83%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-47.33M

Net Income Available to Common(ttm)

-46.13M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.85

52-Week Change

83.81%

S&P 500 52-Week Change

12.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

61.52M

Dividend Yield

0.00%

Float4

17.53M

% Held by Insiders

71.50%

% Held by Institutions

76.95%

Balance Sheet

Total Cash(mrq)

79.03M

Total Cash Per Share(mrq)

1.28

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

11.93%

Quick Ratio(mrq)

11.93%

Book Value Per Share(mrq)

1.29

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.45

Free Cash Flow(ytd)

-27.27M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement